Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Goddemeier T"'
Autor:
Burris HA; Sarah Cannon Research Institute, Nashville, TN, USA. howard.burris@scri.com., Berlin J; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Arkenau T; Drug Development, Ellipses Pharma, London, UK., Cote GM; Division of Hematology and Oncology, Mass General Cancer Center, Boston, MA, USA., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Utrecht, Netherlands.; Amgen Inc., Thousand Oaks, CA, USA., Ferrer-Playan J; Global Clinical Development, Ares Trading SA, an affiliate of Merck KGaA, Eysins, Switzerland., Kalapur A; Global Patient Safety Oncology, Merck Healthcare KGaA, Darmstadt, Germany., Bolleddula J; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., an affiliate of Merck KGaA, Billerica, MA, USA., Locatelli G; Clinical Biomarkers, Merck Healthcare KGaA, Darmstadt, Germany., Goddemeier T; Biostatistics, Merck Healthcare KGaA, Darmstadt, Germany., Gounaris I; Global Clinical Development, Merck Serono Ltd., an affiliate of Merck KGaA, Feltham, UK., de Bono J; Division of Clinical Studies, Institute of Cancer Research, London, UK.; Royal Marsden, Hospital, London, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Apr; Vol. 130 (7), pp. 1131-1140. Date of Electronic Publication: 2024 Jan 29.
Autor:
Mozgunov P; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Jaki T; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.; Computational Statistics Group, University of Regensburg, Regensburg, Germany., Gounaris I; Merck Serono Ltd., an affiliate of Merck KGaA, Feltham, UK., Goddemeier T; Biostatistics, Epidemiology & Medical Writing, Merck Healthcare KGaA, Darmstadt, Germany., Victor A; Biostatistics, Epidemiology & Medical Writing, Merck Healthcare KGaA, Darmstadt, Germany., Grinberg M; Biostatistics, Epidemiology & Medical Writing, Merck Healthcare KGaA, Darmstadt, Germany.; Marianna Grinberg, Statistical Sciences and Innovation, UCB, Monheim, Germany.
Publikováno v:
Statistics in medicine [Stat Med] 2022 Dec 30; Vol. 41 (30), pp. 5789-5809. Date of Electronic Publication: 2022 Nov 25.
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer.
Autor:
Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Tolaney SM; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Shapiro GI; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Middleton M; University of Oxford, Oxford, UK., Lord SR; University of Oxford, Oxford, UK., Arkenau HT; Sarah Cannon Research Institute, HCA Healthcare, London, UK.; University College London, London, UK., Tutt A; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research and Kings College, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK., Abramson V; Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Dean E; The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.; Oncology R&D, AstraZeneca, Cambridge and Alderley Park, Macclesfield, UK., Haddad TC; Mayo Clinic, Rochester, MN, USA., Wesolowski R; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Ferrer-Playan J; Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany., Goddemeier T; the healthcare business of Merck KGaA, Darmstadt, Germany., Grombacher T; the healthcare business of Merck KGaA, Darmstadt, Germany., Dong J; EMD Serono, Billerica, MA, USA., Fleuranceau-Morel P; EMD Serono, Billerica, MA, USA., Diaz-Padilla I; Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany.; GlaxoSmithKline, Zug, Switzerland., Plummer R; Newcastle University and Northern Centre for Cancer Care, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Ruth.Plummer@newcastle.ac.uk.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2022 Apr 07; Vol. 8 (1), pp. 45. Date of Electronic Publication: 2022 Apr 07.
Autor:
Plummer R; Newcastle University and Northern Centre for Cancer Care, Newcastle Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom. Electronic address: Ruth.Plummer@newcastle.ac.uk., Dean E; The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: Emma.Dean@doctors.org.uk., Arkenau HT; Sarah Cannon Research Institute, London, United Kingdom. Electronic address: Tobias.Arkenau@hcahealthcare.co.uk., Redfern C; Sharp Healthcare, San Diego, CA, United States., Spira AI; Virginia Cancer Specialists Research Institute and US Oncology Research, Fairfax, VA, United States., Melear JM; Texas Oncology, Austin, TX, United States. Electronic address: Jason.Melear@usoncology.com., Chung KY; Prisma Health, Greenville, SC, United States. Electronic address: Ki.Chung@prismahealth.org., Ferrer-Playan J; Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany., Goddemeier T; Merck Healthcare KGaA, Darmstadt, Germany., Locatelli G; Merck Healthcare KGaA, Darmstadt, Germany., Dong J; EMD Serono Research & Development Institute, Inc., Billerica, MA, United States., Fleuranceau-Morel P; EMD Serono Research & Development Institute, Inc., Billerica, MA, United States., Diaz-Padilla I; Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany., Shapiro GI; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States. Electronic address: Geoffrey_Shapiro@dfci.harvard.edu.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2022 Jan; Vol. 163, pp. 19-26. Date of Electronic Publication: 2021 Dec 01.
Autor:
Joo, Yoon Ki1,2 (AUTHOR), Ramirez, Carlos1,2 (AUTHOR), Kabeche, Lilian1,2 (AUTHOR) lilian.kabeche@yale.edu
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 20, p3536. 18p.
Autor:
Plummer, R., Cook, N., Arkenau, T., Melear, J., Redfern, C., Spira, A.I., Chung, K., Haddad, T., Ramalingam, S.S., Wesolowski, R., Dean, E., Goddemeier, T., Falk, M., Shapiro, G.
Publikováno v:
In Annals of Oncology October 2018 29 Supplement 8
Autor:
Ruzsa, A., Sen, M., Evans, M., Lee, L., Hideghety, K., Rottey, S., Klimak, P., Holeckova, P., Fayette, J., Csoszi, T., Erfan, J., Forssmann, U., Goddemeier, T., Bexon, A., Nutting, C.
Publikováno v:
Investigational New Drugs; Dec2014, Vol. 32 Issue 6, p1278-1284, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kojima T; National Cancer Center Hospital East, Kashiwa, Chiba, Japan., Yamazaki K; Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan., Kato K; National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Muro K; Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Japan., Hara H; Saitama Cancer Center, Kita Adachi-gun, Saitama, Japan., Chin K; The Cancer Institute Hospital of JFCR, Ariake, Koto, Tokyo, Japan., Goddemeier T; Merck KGaA, Darmstadt, Germany., Kuffel S; Merck KGaA, Darmstadt, Germany., Watanabe M; Merck Serono Co., Ltd., Meguro-ku, Tokyo, Japan., Doi T; National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Publikováno v:
Cancer science [Cancer Sci] 2018 Oct; Vol. 109 (10), pp. 3253-3262. Date of Electronic Publication: 2018 Sep 25.